NCT04622410 Registry for Hirschsprung Disease of the BELAPS
| NCT ID | NCT04622410 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Hirschsprung Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 432 participants |
| Start Date | 2012-05-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 432 participants in total. It began in 2012-05-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Registry for Hirschsprung disease of the BELAPS (Belgian Association of Pediatric Surgery) Protocol Short Title/Acronym / Sponsor name BELAPS Principal Investigator Prof. Dr. Marc Miserez Medical condition or disease under investigation Hirschsprung's disease Purpose of clinical study To register pre-, intra- and postoperative data in order to improve surgical care to paediatric patients with Hirschsprung's disease in Belgium. Primary objective The primary objective is to evaluate defecation habits at 3.5-5.5 years after surgery. Secondary objective (s) Evaluating the long-term results and evaluate risk factors for constipation / incontinence. Study Design Prospective registry Endpoints Krickenbeck score, urinary, sexual and QoL evaluation
Eligibility Criteria
Inclusion Criteria: Hirschsprung Disease, surgery Exclusion Criteria: \-
Contact & Investigator
Colette Barle
✉ colette.barle@uzleuven.beFrequently Asked Questions
Who can join the NCT04622410 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Hirschsprung Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04622410 currently recruiting?
Yes, NCT04622410 is actively recruiting participants. Contact the research team at colette.barle@uzleuven.be for enrollment information.
Where is the NCT04622410 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT04622410 clinical trial?
NCT04622410 is sponsored by Universitaire Ziekenhuizen KU Leuven. The trial plans to enroll 432 participants.